6 matches for your search in the start-up spotlight

rss
matching the following criteria

image description
Accelero Biostructures

Accelero Biostructures was founded in 2015 to capitalis e on over 20 years of previous structural genomics and structural biology expertise using high-throughput protein X-ray crystallography. With the development and deployment of new platforms and services, ABS ServicesSM and ABS-OneStepSM, ...

more

image description
Ebvia, Inc.

Ebvia is a privately held biotechnology company developing a novel, outpatient treatment for breakthrough COVID-19 infections. The drug candidate demonstrated 100% survival against SARS-CoV-2 infection (vs 20% in the control group) in a highly lethal animal model. It also significantly reduced ...

more

image description
insitro

A novel approach to drug development insitro will integrate cutting-edge machine learning techniques with the ground-breaking innovations that have occurred in life sciences that enable the creation of the large, high-quality data sets. We will collect and use a range of very large data sets to ...

more

image description
RDMD, Inc.

RDMD is a healthcare technology company dedicated to accelerating treatments for patients with rare diseases. RDMD has developed a technology platform that generates deep data insights to accelerate rare disease research and drug development, as well as a patient application that empowers ...

more

image description
Atomwise, Inc.

Atomwise uses artificial intelligence to help discover new medicines and agricultural compounds. Its groundbreaking AtomNet technology reasons like a human chemist, using powerful deep learning algorithms and supercomputers to analyze millions of potential molecules each day. Atomwise has ...

more

image description
System1 Biosciences, Inc.

System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE